The Rapid evolution of technology has pushed every industry in a state of flux. The pharmaceutical industry is no exception to this with digitalization taking over medicine, operations, and research alike. Evolution in KOL research
Managing Key Opinion Leaders (KOLs) is a critical yet complex task for Medical Affairs teams. Identifying the right experts, fostering meaningful relationships, and measuring the impact of these engagements are intricate challenges that demand a
If you’re in the pharmaceutical industry, you’re undoubtedly familiar with Key Opinion Leaders (KOLs). These influential healthcare professionals—doctors, nurses, pharmacists, and more—shape the perceptions of drugs and treatments. Their opinions ripple across their networks, influencing
In the fast-evolving world of pharmaceuticals, precision isn’t just a goal—it’s a requirement. The data you rely on can shape your strategy and impact your results. While many pharma companies still lean on syndicated databases
Pharma companies aiming to introduce the next big therapeutic innovations need fresh, innovative strategies to market their products. Engaging with Key Opinion Leaders (KOLs) for feedback and endorsement has long been an effective tactic. While
In the dynamic and ever-evolving pharmaceutical landscape, the role of Medical Affairs is becoming increasingly pivotal. Medical Affairs serves as the essential bridge between the scientific community and the commercial sector, ensuring that cutting-edge research
Sentiment analysis analyzes your KOL’s sentiments towards products, companies, brands and focus areas to understand whether these opinions are positive, negative, or neutral. Sentiment analysis helps pharma companies to engage with KOLs.
Launching a biopharma product is a complex process. The effectiveness of multiple factors, such as a strong pre-launch medical strategy, the role of key healthcare professionals, strategic resource allocation, and launch targeting strategy, often defines
Badal Shah, visionary Founder and President of Neolytica, has been named the 2023-2024 Global Indian of the Year in Healthcare. This prestigious award recognizes Badal’s expertise that has contributed to cutting-edge technologies like Generative AI,
MORRISTOWN, N.J – QPharma, a compliance and commercial services leader in the life sciences industry, is thrilled to announce Mr. Badal Shah, B.Pharm, M.B.S, as President of Neolytica, its healthcare analytics division.
In the ever-evolving landscape of the BioPharma industry, the need for innovative approaches has become more pressing than ever. As traditional marketing channels lose their effect, the industry embraces unconventional methods to identify Key Opinion
In the dynamic landscape of the biopharma industry, where innovation and clinical expertise must converge, it’s not just the well-known figures that make a significant impact. While the superstars often grab the spotlight, there’s an